शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSERoyal Sense Ltd· Healthcare Equipment & SuppliesHighNeutral
Announced Thu, 13 Nov, 2025 · 20:29 IST

Please find enclosed herewith outcome of the meeting for your reference.

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionNegative operating cash flowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-11.8%Reaction day
₹250.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-11.7% vs market
Medical Equipment & Supplies peers, median of 13sector+0.0%-11.8% vs sector

On the reaction day the stock moved 11.7 pts less than Nifty Microcap 250 and 11.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-11.8-0.1-11.7+0.0-11.8
Next day
-7.2+0.5-7.7-1.4-5.8
2d
-10.0-0.3-9.7-2.7-7.3
3d
—-0.5—-3.9—
4d
-12.0-0.8-11.2-3.4-8.6
5d
-16.0-2.3-13.7-5.2-10.8
1w
-18.0-2.8-15.2-5.6-12.4
15d
-1.7-4.9+3.1-4.2+2.5
1m
-14.0-4.7-9.3-3.8-10.2
2m
-34.0-7.7-26.3-10.4-23.6
3m
-30.0-7.8-22.2-11.6-18.4
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Royal Sense Ltd's Board, at its meeting on November 13, 2025, approved unaudited standalone and consolidated financial results for the half-year ended September 30, 2025, along with a Limited Review Report from CND & Associates (unmodified opinion). On a standalone basis, revenue from operations rose to ₹2,075.76 lakhs in H1 FY26, up about 25% from ₹1,657.01 lakhs in H1 FY25. Standalone profit after tax jumped to ₹195.31 lakhs (from ₹111.93 lakhs), with basic EPS of ₹3.65 versus ₹2.28. On a consolidated basis, revenue from operations was ₹4,348.34 lakhs with profit after tax of ₹405.60 lakhs and basic EPS of ₹7.58, reflecting contributions from its wholly-owned subsidiary Stergic Retail Private Limited. The auditor also confirmed full utilization of ₹679.50 lakhs raised via the preferential issue (₹509.63L for working capital and ₹169.87L for general corporate purposes). However, operating cash flow was negative on both standalone (-₹16.66L) and consolidated (-₹1,299.15L) bases, mainly due to a sharp jump in trade receivables.

Likely market impact

Strong top-line and bottom-line growth on a year-on-year basis is a positive signal for shareholders, though the negative operating cash flow and ballooning trade receivables are watchpoints that could pressure short-term liquidity.